Cargando…
How does Nogo receptor influence demyelination and remyelination in the context of multiple sclerosis?
Multiple sclerosis (MS) can progress with neurodegeneration as a consequence of chronic inflammatory mechanisms that drive neural cell loss and/or neuroaxonal dystrophy in the central nervous system. Immune-mediated mechanisms can accumulate myelin debris in the disease extracellular milieu during c...
Autores principales: | Rashidbenam, Zahra, Ozturk, Ezgi, Pagnin, Maurice, Theotokis, Paschalis, Grigoriadis, Nikolaos, Petratos, Steven |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10285164/ https://www.ncbi.nlm.nih.gov/pubmed/37361998 http://dx.doi.org/10.3389/fncel.2023.1197492 |
Ejemplares similares
-
Modulation of the Microglial Nogo-A/NgR Signaling Pathway as a Therapeutic Target for Multiple Sclerosis
por: Nheu, Danica, et al.
Publicado: (2022) -
The Heterogeneous Multiple Sclerosis Lesion: How Can We Assess and Modify a Degenerating Lesion?
por: Ellen, Olivia, et al.
Publicado: (2023) -
Can We Design a Nogo Receptor-Dependent Cellular Therapy to Target MS?
por: Kim, Min Joung, et al.
Publicado: (2018) -
Novel contributors to B cell activation during inflammatory CNS demyelination; An oNGOing process
por: Damianidou, Olympia, et al.
Publicado: (2022) -
The Diversity of Astrocyte Activation during Multiple Sclerosis: Potential Cellular Targets for Novel Disease Modifying Therapeutics
por: Barmpagiannos, Konstantinos, et al.
Publicado: (2023)